Azadeh Sadatnaseri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Azadeh Sadatnaseri has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Alireza Almasi Nokiani
‡Department of Cardiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 shared publicationsFarshad Divsalar
‡Department of Cardiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 shared publicationsMarzieh Bayazidi
‡Department of Cardiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 shared publicationsMohammad Amin Abbasi
‡Department of Cardiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 shared publicationsRazieh Shahnazari
‡Department of Cardiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications- Abbas Soleimani
Mostafa Khomeini Hospital Cardiovascular Research Center School of Medicine Ilam University of Medical Sciences Ilam Iran
1 shared publication
Latest Publications
- Open Access
- 1 March 2023
- Published by Marshfield Clinic Research Institute in Clinical Medicine & Research
- Vol. 21 (1) , 14-25
COVID-19 Chest CT Quantification: Triage and Prognostic Value in Different Ages
Objective: We evaluated the triage and prognostic performance of seven proposed computed tomography (CT)-severity score (CTSS) systems in two different age groups.
- 1 March 2023
- Published by Marshfield Clinic Research Institute in Clinical Medicine & Research
- Vol. 21 (1) , 14-25
Open AccessCOVID-19 Chest CT Quantification: Triage and Prognostic Value in Different Ages
Objective: We evaluated the triage and prognostic performance of seven proposed computed tomography (CT)-severity score (CTSS) systems in two different age groups.
- Open Access
- 24 May 2022
- Published by The Korean Society for Transplantation in Korean Journal of Transplantation
- Vol. 36 (2) , 136-142
The outcomes of marginal donor hearts compared with ideal donors: a single-center experience in Iran
Behnam Shakerian, Sanaz Dehghani, Haleh Ashraf, Shahrokh Karbalai, Abbas Soleimani, Atieh Rezaeefar, Zahra Shajari, Hamidreza Hekmat, Marzieh Latifi, Azadeh Sadatnaseri. Korean J Transplant 2022;36:136-42. https://doi.org/10.4285/kjt.22.0004
- 24 May 2022
- Published by The Korean Society for Transplantation in Korean Journal of Transplantation
- Vol. 36 (2) , 136-142
Open AccessThe outcomes of marginal donor hearts compared with ideal donors: a single-center experience in Iran
Behnam Shakerian, Sanaz Dehghani, Haleh Ashraf, Shahrokh Karbalai, Abbas Soleimani, Atieh Rezaeefar, Zahra Shajari, Hamidreza Hekmat, Marzieh Latifi, Azadeh Sadatnaseri. Korean J Transplant 2022;36:136-42. https://doi.org/10.4285/kjt.22.0004
- Open Access
- 18 May 2022
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 53 (1) , 1-10
CT severity score in COVID-19 patients, assessment of performance in triage and outcome prediction: a comparative study of different methods
Background: Lung involvement in COVID-19 can be quantified by chest CT scan with some triage and prognostication value. Optimizing initial triage of patients could help decrease adverse health impacts of the disease through better clinical management. At least 6 CT severity score (CTSS) systems have been proposed. We aimed to evaluate triage and prognostication performance of seven different CTSSs, including one proposed by ourselves, in hospitalized COVID-19 patients diagnosed by positive polymerase chain reaction (PCR). Results: After exclusion of 14 heart failure and significant preexisting pulmonary disease patients, 96 COVID-19, PCR-positive patients were included into our retrospective study, admitted from February 20, 2020, to July 22. Their mean age was 63.6 ± 17.4 years (range 21–88, median 67). Fifty-seven (59.4%) were men, and 39 (40.6%) were women. All CTSSs showed good interrater reliability as calculated intraclass correlation coefficients (ICCs) between two radiologists were 0.764–0.837. Those CTSSs with more numerous segmentations showed the best ICCs. As judged by area under curve (AUC) for each receiver operator characteristic (ROC) curve, only three CTSSs showed acceptable AUCs (AUC = 0.7) for triage of severe/critical patients. All CTSSs showed acceptable AUCs for prognostication (AUCs = 0.76–0.79). Calculated AUCs for different CTSSs were not significantly different for triage and for prediction of severe/critical disease, but some difference was shown for prediction of critical disease. Conclusions: Men are probably affected more frequently than women by COVID-19. Quantification of lung disease in COVID-19 is a readily available and easy tool to be used in triage and prognostication, but we do not advocate its use in heart failure or chronic respiratory disease patients. The scoring systems with more numerous segmentations are recommended if any future imaging for comparison is contemplated. CTSS performance in triage was much lower than earlier reports, and only three CTSSs showed acceptable AUCs in this regard. CTSS performed better for prognostic purposes than for triage as all 7 CTSSs showed acceptable AUCs in both types of prognostic ROC curves. There is not much difference among performance of different CTSSs.
- 18 May 2022
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 53 (1) , 1-10
Open AccessCT severity score in COVID-19 patients, assessment of performance in triage and outcome prediction: a comparative study of different methods
Background: Lung involvement in COVID-19 can be quantified by chest CT scan with some triage and prognostication value. Optimizing initial triage of patients could help decrease adverse health impacts of the disease through better clinical management. At least 6 CT severity score (CTSS) systems have been proposed. We aimed to evaluate triage and prognostication performance of seven different CTSSs, including one proposed by ourselves, in hospitalized COVID-19 patients diagnosed by positive polymerase chain reaction (PCR). Results: After exclusion of 14 heart failure and significant preexisting pulmonary disease patients, 96 COVID-19, PCR-positive patients were included into our retrospective study, admitted from February 20, 2020, to July 22. Their mean age was 63.6 ± 17.4 years (range 21–88, median 67). Fifty-seven (59.4%) were men, and 39 (40.6%) were women. All CTSSs showed good interrater reliability as calculated intraclass correlation coefficients (ICCs) between two radiologists were 0.764–0.837. Those CTSSs with more numerous segmentations showed the best ICCs. As judged by area under curve (AUC) for each receiver operator characteristic (ROC) curve, only three CTSSs showed acceptable AUCs (AUC = 0.7) for triage of severe/critical patients. All CTSSs showed acceptable AUCs for prognostication (AUCs = 0.76–0.79). Calculated AUCs for different CTSSs were not significantly different for triage and for prediction of severe/critical disease, but some difference was shown for prediction of critical disease. Conclusions: Men are probably affected more frequently than women by COVID-19. Quantification of lung disease in COVID-19 is a readily available and easy tool to be used in triage and prognostication, but we do not advocate its use in heart failure or chronic respiratory disease patients. The scoring systems with more numerous segmentations are recommended if any future imaging for comparison is contemplated. CTSS performance in triage was much lower than earlier reports, and only three CTSSs showed acceptable AUCs in this regard. CTSS performed better for prognostic purposes than for triage as all 7 CTSSs showed acceptable AUCs in both types of prognostic ROC curves. There is not much difference among performance of different CTSSs.
- Open Access
- 1 January 2022
- Vol. 13 (Suppl 3) , 228-235
CT-severity score in COVID-19 patients: for whom is it applicable best?
Background: lung involvement in COVID-19 can be quantified by chest CT scan. We evaluated the triage and prognostication performance of seven proposed CT-severity score (CTSS) systems in two age groups of >= 65 and = 65 and = 65 years old, but is of limited value in younger patients.
- 1 January 2022
- Vol. 13 (Suppl 3) , 228-235
Open AccessCT-severity score in COVID-19 patients: for whom is it applicable best?
Background: lung involvement in COVID-19 can be quantified by chest CT scan. We evaluated the triage and prognostication performance of seven proposed CT-severity score (CTSS) systems in two age groups of >= 65 and = 65 and = 65 years old, but is of limited value in younger patients.